Padma Ladda | Pharmacology | Best Research Article Award

Best Research Article Award

Padma Ladda
Affiliation Appasaheb Birnale College of Pharmacy, Sangli
Country India
Google Scholar ID 6ZyI9VYAAAAJ
Citations 243
h-index 8
i10-index 5
Article Research Paper
Publication Year 2026
Article Views 109
Reference Count 55
Subject Area Pharmacological Screening
Event Indian Scientist Awards
DOI 10.33899/iraqij.p.2026.174043.1290

Padma Ladda

Padma Ladda is a researcher affiliated with Appasaheb Birnale College of Pharmacy, Sangli, India. Her academic profile includes research in pharmacological screening, central nervous system (CNS) research and tuberculosis (TB). Her scholarly record includes an article published in the Iraqi Journal of Pharmacy in 2026, alongside the supplied Google Scholar citation metrics. [1] [2]

Abstract

Padma Ladda is a researcher affiliated with Appasaheb Birnale College of Pharmacy, Sangli, India. Her academic interests include pharmacological screening, central nervous system research and tuberculosis. Her research record includes a 2026 article in the Iraqi Journal of Pharmacy, with an associated DOI and reported Google Scholar indicators reflecting scholarly publication and citation activity. [1] [2]

Keywords

Pharmaceutical Research; Pharmacological Screening; Central Nervous System; CNS Research; Tuberculosis; TB Research; Research Publications; Citation Analysis; Academic Research; Pharmaceutical Sciences; Indian Scientist Awards.

Introduction

Pharmaceutical research contributes to understanding drug activity, therapeutic possibilities and disease-related mechanisms. Pharmacological screening, central nervous system studies and tuberculosis research represent important areas within pharmaceutical sciences. Padma Ladda’s academic profile is associated with these subject areas and Appasaheb Birnale College of Pharmacy, Sangli, reflecting her engagement with pharmaceutical research. [1]

Research Profile

Padma Ladda is affiliated with Appasaheb Birnale College of Pharmacy, Sangli, India. Her identified research interests encompass pharmacological screening, central nervous system studies and tuberculosis. Her Google Scholar profile reports 243 citations, an h-index of 8 and an i10-index of 5, providing bibliometric indicators of her scholarly research activity. [1] [2]

Research Contributions

Her research interests cover pharmacological screening and selected areas of pharmaceutical investigation, including CNS-related studies and tuberculosis. These disciplines involve evaluating biological responses, exploring therapeutic approaches and examining disease-related processes. Her academic contributions can be assessed through published research outputs, their scientific methodology and their relevance to ongoing developments in pharmaceutical sciences. [1] [3]

Publications

The supplied publication record identifies a research paper by Padma Ladda in the Iraqi Journal of Pharmacy, published in 2026. The article is associated with DOI 10.33899/iraqij.p.2026.174043.1290 and has a reported reference count of 55 and 109 article views. These details provide identifiable publication information for scholarly verification. [3]

Research Impact

The supplied Google Scholar profile records 243 citations, an h-index of 8 and an i10-index of 5 for Padma Ladda. These bibliometric measures provide quantitative information about publication visibility and citation activity. Together with her identified journal publication, the indicators offer a useful basis for reviewing her scholarly engagement and academic research profile. [1] [2]

Award Suitability

The Best Research Article Award recognizes scholarly publication and research contributions supported by identifiable academic records. Padma Ladda’s 2026 journal article, DOI information and reported citation indicators provide relevant material for consideration. Her research interests in pharmacological screening, CNS and tuberculosis further establish the academic context of her profile under the Indian Scientist Awards programme. [1] [3]

Conclusion

Padma Ladda’s academic profile reflects engagement with pharmaceutical research through identified subject interests and journal publication activity. Her 2026 research article and reported Google Scholar metrics provide useful indicators for evaluating her scholarly record. The Best Research Article Award acknowledges the relevance of documented publication activity within the Indian Scientist Awards recognition framework. [1] [3]

References

  1. Google Scholar. (n.d.). Author profile: Padma Ladda, Google Scholar ID 6ZyI9VYAAAAJ. Google Scholar.

    https://scholar.google.com/citations?user=6ZyI9VYAAAAJ&hl=en

  2. Iraqi Journal of Pharmacy. (2026). Research article associated with DOI 10.33899/iraqij.p.2026.174043.1290. Iraqi Journal of Pharmacy.

    https://doi.org/10.33899/iraqij.p.2026.174043.1290

  3. Indian Scientist Awards. (n.d.). Official award programme website.

    https://indianscientist.in/

Ritu Dahiya | Pharmacology | Research Excellence Award

Ritu Dahiya | Pharmacology | Research Excellence Award

Linagyas Vidyapeeth  University | India

Dr. Ritu is an accomplished academician and researcher in pharmacology, serving as an Associate Professor with extensive teaching, research, and academic leadership experience. She holds foundational and advanced degrees in pharmacy and is completing her doctoral work in pharmacology. Her professional journey spans university teaching, funded research fellowships, interdisciplinary program development, and scientific mentoring. She has developed expertise in diabetes and its complications, ocular pharmacology, infectious-disease therapeutics, biomarker discovery, and nano-based drug delivery. Her research contributions include high-quality publications in indexed journals, multiple book chapters, edited academic books, and several national and international patents that demonstrate her innovative approach to translational research. She has guided postgraduate dissertations and contributed significantly to curriculum development, scientific event organization, and student training. She has also served as a resource person, evaluator, and invited speaker at scientific conferences and academic forums where her contributions have been recognized through awards and professional acknowledgments. Her work continually focuses on bridging laboratory discovery with therapeutic advancement, especially through natural products, bioflavonoids, molecular mechanisms, and innovative models for disease evaluation. Overall, she is dedicated to advancing pharmacological sciences, fostering research-driven education, and contributing impactful scientific knowledge to improve human health.

Prashant Tiwari | Pharmacology | Excellence in Research Award

Assoc. Prof. Dr. Prashant Tiwari | Pharmacology | Excellence in Research Award

Dayananda Sagar University| India

Dr. Prashant Tiwari is a pharmaceutical scientist and academic specializing in pharmacology, with impactful contributions in neuropharmacology, neurodegenerative disorders, analytical method development, and plant-based therapeutic research. His academic foundation includes advanced qualifications in pharmacy, clinical research, and computational applications, supporting a multidisciplinary research profile. With extensive experience as a faculty member and researcher, he has guided multiple Ph.D. and postgraduate scholars in areas such as Alzheimer’s disease, Parkinson’s disease, drug repurposing, heterocyclic compound synthesis, analytical validation, and formulation development. His scientific output reflects strong research productivity, evidenced by more than 1132 citations, an h-index of 14, an i10-index of 21, and a sustained impact in recent years. He has published peer-reviewed work, developed innovative drug-delivery strategies, and contributed to patents covering microencapsulation, artificial intelligence-based pharmaceutical applications, smart healthcare devices, and phytopharmaceutical compositions. His research interests span neuroprotective mechanisms, AI-assisted drug design, analytical chemistry, phytopharmacology, and preclinical evaluation of novel therapeutic agents. He has also completed multiple national training programs in systematic reviews, ethics in health research, scientific writing, causal inference, Six Sigma, and Good Clinical Practice, strengthening his methodological expertise. Overall, Dr. Tiwari’s work demonstrates a strong commitment to scientific innovation, pharmaceutical education, and translational research.

Profile: Google Scholar

Featured Publications

Bhattacharya, K. S., Tiwari, P., & Sahu, P. K. (2018). A review of the phytochemical and pharmacological characteristics of Moringa oleifera. Journal of Pharmaceutical and Bioallied Sciences, 10(1), 181–191. (Cited by: 298)

Mishra, S. K., Tiwari, P., & Prusty, S. K. (2018). Phytochemistry and pharmacology of Tinospora cordifolia: A review. Systematic Reviews in Pharmacy, 9(1), 70–78. (Cited by: 163)

Mishra, S. K., & Tiwari, P. (2017). Phytochemistry and pharmacology of Tinospora cordifolia: A review. Systematic Reviews in Pharmacy, 9(1), 70–78. (Cited by: 163)

Tiwari, P., Dwivedi, S., Singh, M. P., Mishra, R., & Chandy, A. (2013). Basic and modern concepts on cholinergic receptor: A review. Asian Pacific Journal of Tropical Disease, 3(5), 413–420. (Cited by: 126)

Tiwari, P. (2019). Butea monosperma: Phytochemistry and pharmacology. Acta Scientific Pharmaceutical Sciences, 3(4), 19–26. (Cited by: 51)

PALLAB MANDAL | Pharmacology | Best Researcher Award

Mr. PALLAB MANDAL | Pharmacology | Best Researcher Award

JADAVPUR UNIVERSITY, INDIA

AUTHOR PROFILE

ORCID

EARLY ACADEMIC PURSUITS

Dr. Pallab Mandal’s academic journey demonstrates a rich multidisciplinary foundation in pharmaceutical sciences and life sciences. Beginning with a Bachelor of Science in Zoology, he transitioned into pharmaceutical studies with Diplomas in Pharmacy, Physiotherapy, and Medical Laboratory Technology, later advancing to a Bachelor and Master of Pharmacy at Jadavpur University. He is currently pursuing his Ph.D. in Pharmacology, reinforcing his commitment to scientific advancement and bioanalytical innovation.

PROFESSIONAL ENDEAVORS

With nearly a decade of experience, Dr. Mandal serves as the Head of Quality Assurance and Senior Bioanalyst (LC-MS/MS) at Taab BioStudy Services, a CDSCO-approved and GLP-accredited CRO. He leads laboratory operations, ensures compliance with GLP standards, and guides method development. His academic involvement as a faculty member at Jadavpur University’s Bioequivalence Study Centre highlights his dual role as both a researcher and educator.

CONTRIBUTIONS AND RESEARCH FOCUS IN PHARMACOLOGY

Dr. Mandal’s research centers around bioanalytical method development, pharmacokinetics, and therapeutic drug monitoring using LC-MS/MS and HPLC platforms. His notable pharmacology research includes:

  • Quantitative analysis of antihypertensive drug combinations,

  • Pharmacokinetic modeling of DPP-4 inhibitors,

  • Evaluation of anticancer potential of natural compounds like Triticum aestivum on MCF-7 breast cancer cell lines,

  • Collaborative international work on Diosmetin and Hesperitin.

ACCOLADES AND RECOGNITION

Dr. Mandal has earned a range of national and international recognitions:

  • M.N. Dev Memorial Award for academic excellence in D.Pharm.

  • IDMA Award 2018 for best research in pharmaceutical analysis.

  • INSO International Scientist Award (2022) for multidisciplinary contributions.

  • International ICON Award (2024) for excellence in pharmacological research.
    He has also contributed book chapters in reputed pharmacology publications, expanding on drug mechanisms in hypertension, antibacterial therapy, and diuretic pharmacology.

IMPACT AND INFLUENCE

Dr. Mandal’s work contributes to bioequivalence studies, clinical pharmacology, and biomarker-based drug evaluations. His methodologies aid in improving drug efficacy evaluations, regulatory submissions, and healthcare analytics modeling. His conference participations and global presentations—most notably in USA, Malaysia, and India—have helped disseminate high-impact research in pharmacological sciences.

LEGACY AND FUTURE CONTRIBUTIONS

A recognized thought leader in bioanalytical pharmacology, Dr. Mandal’s future contributions are expected to delve deeper into cancer pharmacotherapy, drug metabolism studies, and data-driven pharmacokinetic modeling. His role in mentoring young researchers and advocating for regulatory-quality assurance in pharmacological studies promises to shape the next generation of clinical researchers.

NOTABLE PUBLICATIONS:

Title: An Audit on Design of Pharmaceutical Packaging
Authors: Pallab Mandal, Jasmina Khanam, Sanmoy Karmakar, Tapan Kumar Pal, Sujata Barma, Soumya Chakraborty, Rakesh Bera, Sourav Poddar
Journal: Journal of Packaging Technology and Research
Year: 2022


Title: Analytical Method Development and Validation of Trimethylazanium Containing Anti-leishmanial Phospholipid Drug Miltefosine by Liquid Chromatography Quadruple Tandem Mass Spectrometry (LC-ESI-MS/MS) API-2000
Authors: Pallab Mandal, Pradip Kundu, Soumya Chakraborty, Rakesh Bera, Nilendra Chatterjee, Sourav Poddar, D.P. Ghosh, Tapan Kumar Pal
Journal: Research Journal of Pharmacy and Technology
Year: 2022


Title: Anti-Hypertensive Activity of Some Selected Unani Formulations: An Evidence-Based Approach for Verification of Traditional Unani Claims Using LC-MS/MS for the Evaluation of Clinically Relevant Blood Parameters in Laboratory Rats
Authors: Pallab Mandal, Md. Adil Shaharyar, Rudranil Bhowmik, Obaid Afzal, Abdulmalik S. A. Altamimi, Sami I. Alzarea, Waleed Hassan Almalki, Sk Zeeshan Ali, Avishek Mandal et al.
Journal: Journal of Clinical Medicine
Year: 2022


Title: A Novel Validated Bio-Analytical Method Development for Azelnidipine (Dihydropyridine) in Indian Human Plasma by Liquid Chromatography Quadruple Tandem Mass Spectrometry (LC-ESI-MS/MS, API-4000) with an Application to In Vivo Pharmacokinetic and Bioequivalence Study
Authors: Pallab Mandal, Soumya Chakraborty, Rakesh Bera, Chiranjit Saha, Tapan K. Pal, Balaram Ghosh, Sourav Poddar
Journal: Indian Drugs
Year: 2022


Title: Internal Standard: An Important Analyte Used in Drug Analysis by Liquid Chromatography Mass Spectrometry – An Article
Authors: Pallab Mandal
Journal: International Journal of Pharmaceutical and Bio-Medical Science
Year: 2022

CONCLUSION

Dr. Pallab Mandal exemplifies excellence in bioanalytical research, pharmacological innovation, and academic mentorship. His combined experience in GLP-certified environments, his international exposure, and his scholarly rigor position him as a valuable contributor to global pharmaceutical sciences. His dedication to advancing analytical methodologies, drug safety evaluation, and clinical pharmacology research continues to influence both academia and industry.

Rishabh Gaur | Pharmacology | Best Researcher Award

Mr. Rishabh Gaur | Pharmacology | Best Researcher Award

Roorkee College of Pharmacy- India

Author Profile

Early Academic Pursuits

Rishabh Gaur’s academic journey commenced with his Bachelor of Pharmacy (B. Pharm.) from Rajiv Academy for Pharmacy, Mathura, where he graduated in 2021 with an impressive 8.01 CGPA. This foundational education provided him with a strong background in pharmaceutical sciences, laying the groundwork for his subsequent academic and professional endeavors.

Professional Endeavors

Building on his undergraduate education, Rishabh pursued a Master of Pharmacy (M. Pharm.) specializing in Pharmacology from Rajiv Academy for Pharmacy, Mathura, graduating in 2023 with an excellent 8.06 CGPA. His academic achievements equipped him with advanced knowledge and skills in pharmacological sciences, preparing him for a career in academia and research.Currently, Rishabh Gaur serves as an Assistant Professor at Roorkee College of Pharmacy, Roorkee, where he has been contributing since January 2024. His role involves teaching and mentoring students, guiding undergraduate research projects, and taking on administrative responsibilities within the college.

Contributions and Research Focus

Rishabh’s research focuses on Pharmacological Evaluation and Unraveling Mechanism of Thevetia peruviana Leaves for Predicted Treatment of Peptic ulcer disease. This underscores his commitment to advancing pharmacological research aimed at developing potential treatments for prevalent diseases.

Accolades and Recognition

Rishabh Gaur has been recognized as an Editorial Board Member at the 1st Edition of the World Electronic Materials Conference held in Singapore on March 13th, 2024. This acknowledgment highlights his scholarly contributions and expertise in pharmaceutical research, reinforcing his standing in the academic community.

Impact and Influence

Through his role as an Assistant Professor and his research endeavors, Rishabh Gaur is making a significant impact on the field of pharmacology and pharmaceutical sciences. His contributions in mentoring students, conducting research, and participating in academic committees are shaping the next generation of pharmaceutical professionals.

Legacy and Future Contributions

Looking ahead, Rishabh aims to continue his contributions to pharmacological research, focusing on developing innovative treatments and advancing the understanding of drug mechanisms. His legacy is poised to encompass advancements in pharmacology that address critical healthcare challenges, paving the way for improved therapies and patient outcomes. By fostering a supportive learning environment and engaging in impactful research, Rishabh Gaur seeks to leave a lasting mark on the field of pharmacy and pharmaceutical sciences.